HIGHLIGHTS
- who: Maitri V. Acharekar et al. from the California Institute of Behavioral and, USA Research, California Institute of have published the paper: Received 06/16/2022 Review began 07/13/2022 Review ended 07/26/2022 Published 08/04/2022, in the Journal: (JOURNAL) of August/04,/2022
- what: SSRIs are quite efficient and safe in improving the global symptoms of Gastrointestinal motility disorders or DGBI, especially in cases of IBS-C.
- how: Were obtained using node strength and were statistically significant.
SUMMARY
The basic search was carried out . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.